explore -WSS

explore

author：fashion 2025-10-01 15:31:52 - browse：95551

Venture capital firm RA Capital is starting a new incubator, setting the stage for the firm to create new startups over the next several years that hone in on synthetic biology, a long-gestating field that insiders say is getting renewed interest.

The Boston-based VC’s incubator is called RASyn, and will be led by Robert Nicol, according to people familiar with the firm’s plans. Nicol spent more than 20 years at the Broad Institute, where he co-founded the MIT-Broad Foundry for Synthetic Biology, as well as HiFiBio Therapeutics and Design Pharmaceuticals.

RA Capital confirmed RASyn’s existence. Senior Managing Director Josh Resnick told STAT it’s part of the firm’s work to rethink how it develops platforms — core technologies or scientific approaches that underpin all of the drugs a biotech develops — but declined to comment further.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： Flu vaccine offering decent levels of protection this winter, new data show

focus

WSS

RaDonda Vaught to speak at CommonSpirit event on patient safety

Pfizer highlights cancer drugs it thinks could reignite investor interest

The unintended consequences of overturning Roe v. Wade

FDA does about

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Pfizer highlights cancer drugs it thinks could reignite investor interest

focus

explore

focus

Medicare details structure of new drug price negotiation program

Free Covid tests will again be offered to all U.S. households

Anesthesiologist group: stop taking Ozempic before surgery

Why getting cancer drugs just got harder for rural patients

How to save PrEP access — and even expand it

White House Covid adviser calls on docs to combat misinformation

Moonlake's readout produced a cash windfall. Risks remain

Free Covid tests will again be offered to all U.S. households

State Dept. review finds Biden bears some blame for Afghanistan failures

House panel takes first step toward fixing drug shortages

hotspot

Midwives could help bridge maternal health disparities in the U.S.

Chamber of Commerce, DOJ clash in court over drug prices

An inside look at PIPEs, biotech's buzzy new financing tool

Assistant physicians can help address the primary care shortage

Clinical trials giant ICON acquires HumanFirst

Covid isolation guidance eased by the CDC

focus

hotspot

focus

explore